Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Treasury Shares: 2018-2025

Historic Treasury Shares for Aytu Biopharma (AYTU) over the last 8 years, with Jun 2025 value amounting to $32,912.

  • Aytu Biopharma's Treasury Shares rose 72.12% to $31,294 in Q3 2025 from the same period last year, while for Sep 2025 it was $31,294, marking a year-over-year increase of 72.12%. This contributed to the annual value of $32,912 for FY2025, which is 36.54% up from last year.
  • Latest data reveals that Aytu Biopharma reported Treasury Shares of $32,912 as of FY2025, which was up 36.54% from $24,105 recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Treasury Shares ranged from a high of $2.0 million in FY2021 and a low of $24,105 during FY2024.
  • In the last 3 years, Aytu Biopharma's Treasury Shares had a median value of $32,912 in 2025 and averaged $31,697.
  • Per our database at Business Quant, Aytu Biopharma's Treasury Shares surged by 367.26% in 2021 and then crashed by 95.89% in 2022.
  • Yearly analysis of 5 years shows Aytu Biopharma's Treasury Shares stood at $2.0 million in 2021, then plummeted by 95.89% to $80,373 in 2022, then slumped by 52.63% to $38,075 in 2023, then plummeted by 36.69% to $24,105 in 2024, then surged by 36.54% to $32,912 in 2025.